(Q46397414)

English

Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system

scientific article published on 2 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

author name string

U Kinnunen

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

H Syrjälä

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

P Koistinen

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

M Koskela

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

publication date

2 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

28

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

301-303

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0613-4

21 January 2018

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of oral thioguanine in acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of anti-neoplastic agents on the recovery of bacteria and yeasts in an automated blood culture system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18763001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-008-0613-4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18763001

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46397414&oldid=2207840131"